Page last updated: 2024-09-03

acea 1011 and anandamide

acea 1011 has been researched along with anandamide in 1 studies

Compound Research Comparison

Studies
(acea 1011)
Trials
(acea 1011)
Recent Studies (post-2010)
(acea 1011)
Studies
(anandamide)
Trials
(anandamide)
Recent Studies (post-2010) (anandamide)
12012,56629957

Protein Interaction Comparison

ProteinTaxonomyacea 1011 (IC50)anandamide (IC50)
Fatty-acid amide hydrolase 1Homo sapiens (human)3.75
Potassium channel subfamily K member 3Homo sapiens (human)3
Potassium channel subfamily K member 2 Bos taurus (cattle)1
Transient receptor potential cation channel subfamily V member 2Rattus norvegicus (Norway rat)4.78

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fröhlich, K; Schäfer, F; Schmidt, W; Striggow, F; Striggow, V1

Other Studies

1 other study(ies) available for acea 1011 and anandamide

ArticleYear
Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
    Neuroscience, 2012, Dec-27, Volume: 227

    Topics: Animals; Arachidonic Acids; Brain; Brain Infarction; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Endocannabinoids; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Indans; Infarction, Middle Cerebral Artery; Leukocyte Common Antigens; Male; Movement Disorders; Neuroprotective Agents; Polyunsaturated Alkamides; Psychomotor Performance; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids; Time Factors

2012